EX-10.5 4 btmd-ex10_5.htm EX-10.5 EX-10.5

 

展覽10.5

執行版本

信貸協議及豁免的第一修正案

這份關於信用協議及豁免的首次修正,日期爲2024年4月26日,由BIOTE醫療有限責任公司(一家德克薩斯州有限責任公司)、以及BIOTE控股有限責任公司(一家特拉華州有限責任公司)等簽署。協議,日期爲2024年4月26日,由 BIOTE 醫療有限責任公司(一家德克薩斯州有限責任公司)及 BIOTE 控股有限責任公司(一家特拉華州有限責任公司)等簽署入。第一修正案生效日期,由 BIOTE 醫療有限責任公司(一家德克薩斯州有限責任公司)及 BIOTE 控股有限責任公司(一家特拉華州有限責任公司)等簽署。借款人,一家特拉華州有限責任公司Holdings),其他擔保方,貸款方以及作爲行政代理的Truist銀行(“行政代理人”).

鑑於,計劃第17.2節保留了Celldex Therapeutics,Inc.(以下稱爲「公司」)董事會(以下稱爲「董事會」)修訂計劃的權利;和

鑑於,借款人、控股公司、其他擔保方、貸款人和管理代理已經簽訂了某項信貸協議,日期爲2022年5月26日(被修訂、重訂、被修訂和重訂、補充、增加、延長、再融資、續約、更換和/或以書面形式不時修改的,該“授信協議 (Credit Agreement)”);

鑑於,借款方未能遵守信用協議第7.5節中規定的條款,同意根據多諾維茲和解協議(在本協議的定義中)爲購買母公司和控股公司股票進行受限支付,並因此,信用協議已發生違約事件(稱爲“指定事件 違約”);

鑑於借款人請求放棄特定違約事件並修改信貸協議如下,在本協議規定的條款和條件下;

鑑於,放款人(由構成必要放款人和必要循環放款人的放款人行爲)已同意放棄特定違約事件,並根據本文所載條款和條件對信貸協議進行請求的修訂。

現在,鑑於本協議所載內容併爲其他有價值的考慮,茲特確認各方已收到並認可足額,特此各方一致同意如下:

協議

1.
介紹性段落和背景資料; 定義上述介紹性段落和背景資料(包括其中定義的任何條款)已被引用並作爲本協議的一部分納入,如同完整地載於本協議正文。本協議中使用但未在此處另有定義的大寫詞彙,應當具有在信貸協議中所賦予的相應含義(本協議對該協議進行了修訂,或在本協議生效之前立即生效的情況下,根據情境可能需要的效力)。
2.
豁免特定違約事件;釋放。
(a)
根據信貸協議第11.2節(放棄; 修訂),在滿足本協議中列明的所有條款和條件的前提下,債權人(由構成強制債權人和強制循環貸款人的債權人行使)特此豁免指定違約事件,並同意指定違約事件不再繼續適用於信貸協議和其他貸款文件的目的。除了本 。每個認購單位應支付的購買價格應等於每個企業單位在 第2(a)章 中的價格。中明確豁免的內容外,本 。每個認購單位應支付的購買價格應等於每個企業單位在 第2(a)章 中的價格。 中的任何內容均不得被解釋爲對信貸協議或任何其他貸款文件的修改,也不得被視爲放棄(i)任何權利或

 


 

本處所述的豁免不排除行使信貸協議或任何其他貸款文件下管理員代理、任何放款人、開證銀行或攤融放款人可能具有的任何救濟權或適用法律下的義務,也不排除任何貸款方完全遵守信貸協議或任何其他貸款文件中包含的任何職責、條款、條件、義務或契約。本處所述的豁免 。每個認購單位應支付的購買價格應等於每個企業單位在 第2(a)章 中的價格。 僅爲一次性豁免,僅在涉及指明違約事件時有效,不得要求管理員代理、任何放款人、開證銀行或攤融放款人豁免任何其他現有或今後產生的違約或違約事件。本協議規定的條款和協議不得建立管理員代理、任何放款人、開證銀行、攤融放款人和/或任何貸款方之間的慣例或債務處理方式。
(b)
考慮到貸款人願意簽訂本協議,各貸款方特此解除行政代理人、每家貸款機構、髮卡銀行和Swingline貸款人(各爲”指定當事方” 總的來說,”特定當事方”),以及每個特定方的每位前任、繼任者、受讓人、高級職員、經理、董事、員工、代理人、律師、代表和關聯公司(以下簡稱 「上述所有人員,以及特定各方,統稱爲」貸款人集團”)來自任何和所有索賠、反訴、要求、損害賠償、債務、訴訟、責任、訴訟和任何性質的訴訟原因,均限於與貸款文件或在第一修正案生效日當天或之前由貸款文件引起或與貸款文件相關的任何談判、活動、事件或情況,無論是法律還是權益,無論是已知還是未知,無論責任是直接還是間接的流動資金,已清算或未清算,無論是絕對的還是偶然的,可預見的還是不可預見的,以及無論此前是否斷言,該貸款方可能對貸款人集團的任何成員持有或聲稱擁有何種說法。
3.
信用協議修訂事項根據信貸協議第11.2節的規定,經構成必要貸款人和必要循環貸款人的貸款人行爲,信貸協議如下進行修改:放棄; 修訂根據信貸協議第11.2節的規定,經構成必要貸款人和必要循環貸款人的貸款人行爲,信貸協議如下進行修改:
(a)
“貸款協議第1.1節中""Consolidated Fixed Charges""的定義中的第(b)款被完全修改如下:“貸款協議第1.1節中""Consolidated Fixed Charges""的定義中的第(b)款被完全修改如下:“貸款協議第1.1節中""Consolidated Fixed Charges""的定義中的第(b)款被完全修改如下:定義“貸款協議第1.1節中""Consolidated Fixed Charges""的定義中的第(b)款被完全修改如下:
(b)
在此期間就《合併總債務》支付的正常計劃本金還款(排除義務性預付款項)進行支付(爲避免疑問,不包括(i)根據 第2.12節。“(ii)資不抵債不導致承諾減少的循環貸款支付(包括但不限於循環貸款),(iii)控股及其子公司之間的公司間債務支付,以及(iv)根據Donovitz解決協議允許的向母公司回購股本的支付)支付情形。' '第7.5(d)條')以及在該期間由控股及其子公司以現金支付的資本租賃債務,每種情況都以最近結束的四(4)個財務季度的合併基礎進行衡量。四(4)個最近結束的財政季度期間,按合併基礎衡量控股及其子公司支付的《資本租賃租約》款項。
(b)
信貸協議的1.1節(定義)被修改以按照適當的字母順序插入以下定義的術語:

Donovitz和解協議”意指2024年4月23日生效的某項和解協議,涉及 inter alios,母公司和Gary S. Donovitz博士。

(c)
In Section 1.1 (Definitions) of the Credit Agreement, the definition of “Material Agreements” is hereby amended in its entirety to read as follows:

2


 

Material Agreements” shall mean (i) all agreements, indentures or notes governing the terms of any Material Indebtedness, (ii) the Donovitz Settlement Agreement, and (iii) all other agreements, documents, contracts, indentures and instruments pursuant to which (A) any Loan

Party or any of its Subsidiaries are obligated to make payments in any twelve month period in excess of the Threshold Amount, (B) any Loan Party or any of its Subsidiaries expects to receive revenue in any twelve month period in excess of the Threshold Amount and (C) a default, breach or termination thereof could reasonably be expected to result in a Material Adverse Effect.

(d)
Clause (d) in Section 7.5 (Restricted Payments) of the Credit Agreement is hereby amended in its entirety to read as follows:

(d) payments for repurchases of Capital Stock in the Parent pursuant to the Donovitz Settlement Agreement in amounts equal to (i) $32,162,261.67 on the date that is three business days after the effective date of the Donovitz Settlement Agreement (such date, the “Settlement Agreement Closing Date”), (ii) $15,081,130.83 on or before the 12-month anniversary of the Settlement Agreement Closing Date, (iii) $19,081,130.83 on or before the 24-month anniversary of the Settlement Agreement Closing Date, and (iv) $10,540,565.42 on or before the 36-month anniversary of the Settlement Agreement Closing Date;

4.
Effectiveness; Condition Precedent. This Agreement shall become effective as of the First Amendment Effective Date upon receipt by the Administrative Agent of a counterpart of this Agreement duly executed by each of the Administrative Agent, Lenders constituting Required Lenders and Required Revolving Lenders, the Borrower, Holdings, and the other Guarantors.
5.
Miscellaneous.
(a)
This Agreement shall be deemed to be, and is, a Loan Document.
(b)
Effective as of the First Amendment Effective Date, all references to the Credit Agreement in each of the Loan Documents shall hereafter mean the Credit Agreement as amended by this Agreement.
(c)
Except as expressly modified by this Agreement, the Credit Agreement, the Loan Documents, and the obligations of each Loan Party thereunder and under the other Loan Documents are hereby ratified and confirmed and shall continue and remain in full force and effect according to their respective terms.
(d)
Each of the Loan Parties: (i) acknowledges and consents to all of the terms and conditions of this Agreement; (ii) agrees that this Agreement, and all documents executed in connection herewith, do not operate to reduce or discharge any of its obligations under the Credit Agreement or the other Loan Documents, or any certificates, documents, agreements and/or instruments executed in connection herewith or therewith; (iii) affirms all of its respective obligations under the Loan Documents; (iv) agrees that this Agreement shall in no manner impair, or otherwise adversely affect, any of the Liens granted in, or pursuant to, any of the Loan Documents; and (v) affirms that each of the Liens granted in, or pursuant to, any of the Loan Documents is valid and subsisting.
(e)
Each of the Loan Parties hereby represents and warrants to the Administrative Agent and each of the Lenders as follows:
(i)
such Loan Party has taken all necessary action to authorize the execution, delivery and performance of this Agreement;
(ii)
this Agreement has been duly executed and delivered by such Loan Party and constitutes such Loan Party’s legal, valid and binding obligations, enforceable in accordance with

3


 

its terms;
(iii)
no consent, approval, authorization or order of, or filing, registration or qualification with, any court or governmental authority or third party is required in connection with the execution, delivery or performance by any Loan Party of this Agreement;
(iv)
after giving effect to this Agreement, all representations and warranties of each Loan Party set forth in the Loan Documents are true and correct in all material respects (other than those representations and warranties that are expressly qualified by a Material Adverse Effect or other materiality, in which case such representations and warranties are true and correct in all respects) except to the extent that such representations and warranties specifically refer to an earlier date, in which case they are true and correct in all material respects (other than those representations and warranties that are expressly qualified by a Material Adverse Effect or other materiality, in which case such representations and warranties are true and correct in all respects) as of such earlier date; and
(v)
after giving effect to this Agreement, no Default or Event of Default exists.
(f)
This Agreement may be executed by one (1) or more of the parties to this Agreement on any number of separate counterparts (including by telecopy), and all of said counterparts, taken together, shall be deemed to constitute one (1) and the same instrument. Delivery of an executed counterpart of a signature page of this Agreement by facsimile transmission or by any other electronic imaging means (including in “.pdf” form), shall be effective as delivery of a manually executed counterpart of this Agreement.
(g)
THIS AGREEMENT, AND ANY CLAIMS, CONTROVERSIES, DISPUTES OR CAUSES OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF, OR RELATING TO THIS AGREEMENT, AND/OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY, SHALL BE CONSTRUED IN ACCORDANCE WITH, AND BE GOVERNED BY, THE LAWS (WITHOUT GIVING EFFECT TO THE CONFLICT OF LAW PRINCIPLES THEREOF) OF THE STATE OF NEW YORK.
6.
Reaffirmation of Obligations. Each of the Loan Parties: (a) acknowledges and consents to all of the terms and conditions of this Agreement; (b) affirms all of its obligations under the Loan Documents (as amended by this Agreement); and (c) agrees that this Agreement, and all documents, agreements and instruments executed in connection with this Agreement, do not operate to reduce or discharge such Loan Party’s obligations under the Loan Documents (except to the extent that such obligations are expressly modified pursuant to this Agreement).
7.
Reaffirmation of Security Interests. Each of the Loan Parties: (a) affirms that each of the Liens granted in, or pursuant to, any of the Loan Documents is valid and subsisting; and (b) agrees that this Agreement, and all documents, agreements and instruments executed in connection with this Agreement, do not, in any manner, impair, or otherwise adversely affect, any of the Liens granted in, or pursuant to, any of the Loan Documents.
8.
No Other Changes. Except as expressly modified hereby, all of the terms and provisions of the Loan Documents shall remain in full force and effect.

 

[Remainder of Page Intentionally Left Blank; Signature Pages Follow]

4


 

IN WITNESS WHEREOF, each of the parties hereto has caused a counterpart of this Agreement to be duly executed and delivered by their respective authorized officers as of the day and year first above written.

 

BORROWER:

BIOTE MEDICAL, LLC,

a Texas limited liability company

 

 

 

 

 

 

By:

 

BIOTE HOLDINGS, LLC, its Sole Member

 

By:

 

BIOTE CORP., its Managing Member

 

 

 

 

 

 

 

 

 

By:

 

/s/Robert Peterson

 

Name:

 

Robert Peterson

 

Title:

 

Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

GUARANTORS:

BIOTE HOLDINGS, LLC,

a Delaware limited liability company

 

 

 

 

 

 

 

 

 

 

By:

 

BIOTE CORP., its Managing Member

 

 

 

 

 

 

 

 

 

By:

 

/s/Robert Peterson

 

Name:

 

Robert Peterson

 

Title:

 

Chief Financial Officer

 

 

 

 

 

 

 

 

 

BIOTE IP, LLC,

a Nevada limited liability company

 

 

 

 

 

 

 

 

 

 

By:

 

/s/Robert Peterson

 

Name:

 

Robert Peterson

 

Title:

 

Chief Financial Officer

 

Signature Page to First Amendment to Credit Agreement and Waiver (BioTE Medical, LLC)

 


 

 

ADMINISTRATIVE AGENT:

TRUIST BANK,

as the Administrative Agent

 

 

 

 

 

 

By:

 

/s/Troy R. Weaver

 

Name:

 

Troy R. Weaver

 

Title:

 

Managing Director

 

 


 

 

LENDERS:

TRUIST BANK,

 

as a Lender, the Issuing Bank and the Swingline Lender

 

 

 

 

 

 

 

 

 

By:

 

/s/Troy R. Weaver

 

Name

 

Troy R. Weaver

 

Title:

 

Managing Director

 

 

 

 

 

 

 

 

 

 


 

 

 

BANK OF AMERICA, N.A.,

 

as a Lender

 

 

 

 

 

 

 

 

 

By:

 

/s/Alexander L. Rody

 

Name

 

Alexander L. Rody

 

Title:

 

Senior Vice President

 

 

 

 

 

 

 

 

 

 

 


 

 

 

WELLS FARGO BANK, NATIONAL ASSOCIATION,

 

as a Lender

 

 

 

 

 

 

 

 

 

By:

 

/s/Matthew Beltman

 

Name

 

Matthew Beltman

 

Title:

 

Director